Completed PHASE1/PHASE2 INTERVENTIONAL 3-arm NCT00638248

Dose Escalation of Desmoteplase in Acute Ischemic Stroke (DEDAS) (DEDAS)

International, Multicenter, Double-Blind, Placebo-Controlled, Randomized Phase I/II Trial of Desmoteplase in the Indication of Acute Ischemic Stroke

Sponsor: PAION Deutschland GmbH

Conditions Stroke

Interventions Desmoteplase Placebo

Updated 5 times since 2017 Last updated: Mar 12, 2008 Started: Mar 31, 2003 Primary completion: Oct 31, 2004 Completion: Oct 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Stroke, this trial is completed. The trial is conducted by PAION Deutschland GmbH and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1/PHASE2

Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1_PHASE2
Feb 2017 — Jan 2021 [monthly]

Completed PHASE1_PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE1_PHASE2

First recorded

Mar 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PAION Deutschland GmbH

Data source: PAION Deutschland GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.